MM

Marcos Milla

Venture Partner at Samsara BioCapital

Carlsbad, California

Investor
VC

Invests in

Stages:

Series A
Seed

  • Min Investment:

    $10,000,000.00

  • Max Investment:

    $100,000,000.00

  • Target Investment:

    $25,000,000.00

Skills

Protein Chemistry
Biotechnology
Biophysics
Biochemistry
Protein-protein Interactions
Biomarker Discovery
In Vitro
Signal Transduction
Medicinal Chemistry
Immunology
Molecular Biology
Oncology
Drug Discovery
Pharmaceutical Industry
Cell
Inflammation
Lifesciences
GPCRs
Assay Development
Pharmacology

Education

Investments

Enlaza Therapeutics

Seed

Total Funding: $160M

Tentarix Biotherapeutics

Series A

Total Funding: $85M

ImmunOs Therapeutics

Series B

Total Funding: $88M

Work Experience

Universidad Peruana Cayetano Heredia Board of Patrons

2023

  • Member

    2023

    Universidad Peruana Cayetano Heredia is a top institution in Latin America for education and research in biomedical sciences. We are boosting institutional development through its Board of Patrons (Patronato)

Samsara BioCapital

2021

  • Venture Partner

    2021

The Milla Goni Family Foundation

2020

  • President

    2020

    The Milla Goni Family Foundation creatively curates and provides access to capital, research, and connections to Peruvian change-makers from marginalized communities to launch mutualist, restorative solutions in healthcare, food + water justice, equitable labor + income, and decolonized education: https://themillagonifoundation.org/

Synthorx Inc

2017 - 2021

  • Chief Scientific Officer

    2018 - 2021

  • Senior Vice President of Research

    2017 - 2018

Adaptive Biotechnologies Corp.

2016 - 2017

  • Vice President, Therapeutics

    2016 - 2017

Janssen, Pharmaceutical Companies of Johnson and Johnson

2009 - 2016

  • Global Head, Emerging Science & Innovation, Discovery Sciences

    2014 - 2016

  • Scientific Director and Fellow, Immunology Discovery

    2009 - 2014

    Team Leader - Exploratory Platforms

Roche Pharmaceuticals

2005 - 2009

  • Director

    2005 - 2009

University of Pennsylvania School of Medicine

1998 - 2005

  • Professor

    1998 - 2005

    Research on the structure and function of the TNF-alpha converting enzyme (TACE)

GlaxoSmithKline

1995 - 1998

  • Research Investigator

    1995 - 1998

MIT

1990 - 1993

  • Post Doctoral Fellow

    1990 - 1993